Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PHG | US
-0.16
-0.58%
Healthcare
Diagnostics & Research
30/06/2024
24/04/2026
27.47
27.38
27.54
27.28
Koninklijke Philips N.V. operates as a health technology company in North America the Greater China and internationally. It operates through Diagnosis & Treatment Businesses Connected Care Businesses and Personal Health Businesses segments. The company provides diagnostic imaging solutions includes magnetic resonance imaging X-ray systems and computed tomography (CT) systems and software comprising detector-based spectral CT solutions as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis treatment planning and guidance for cardiology general imaging obstetrics/gynecology and point-of-care applications; integrated interventional systems and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition the company provides power toothbrushes brush heads and interdental cleaning and teeth whitening products; infant feeding baby monitors and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth Prisma Health and the University Health System of San Antonio to help the health system standardize patient monitoring drive interoperability and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam the Netherlands.
View LessLargecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Price Below SMA10D
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
29.8%1 month
29.6%3 months
35.6%6 months
31.5%-
15.60
2.29
0.70
0.28
24.38
1.87
0.38
1.38B
25.60B
25.60B
-
6.23
585.30
-0.20
-4.59
3.27
0.12
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.67
Range1M
3.52
Range3M
7.37
Rel. volume
0.86
Price X volume
22.05M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Mettler-Toledo International Inc | MTD | Diagnostics & Research | 1282.45 | 27.21B | 1.43% | 37.74 | -1347.12% |
| Veeva Systems Inc | VEEV | Health Information Services | 161.13 | 26.09B | 3.19% | 59.18 | 1.04% |
| Natera Inc | NTRA | Diagnostics & Research | 203.75 | 25.20B | 1.30% | n/a | 52.31% |
| DexCom Inc | DXCM | Diagnostics & Research | 61.57 | 24.67B | -1.80% | 44.96 | 106.57% |
| Laboratory Corporation of America Holdings | LH | Diagnostics & Research | 263.8 | 22.15B | -0.42% | 40.18 | 74.63% |
| Quest Diagnostics Incorporated | DGX | Diagnostics & Research | 196.27 | 21.85B | -1.63% | 20.22 | 76.89% |
| Illumina Inc | ILMN | Diagnostics & Research | 127.88 | 20.37B | 1.95% | n/a | 203.41% |
| Waters Corporation | WAT | Diagnostics & Research | 309.87 | 18.39B | -0.43% | 34.84 | 147.93% |
| Medpace Holdings Inc | MEDP | Diagnostics & Research | 410.54 | 12.73B | 4.35% | 33.43 | 20.13% |
| Guardant Health Inc | GH | Diagnostics & Research | 88.91 | 10.94B | 1.18% | n/a | -83144.02% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Twenty-First Century Fox Inc | FOXA | Media - Diversified | 62.85 | 27.58B | -2.60% | 13.57 | 76.09% |
| Twenty-First Century Fox Inc | FOX | Media - Diversified | 56.17 | 26.86B | -2.72% | 12.45 | 76.09% |
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| Dolby Laboratories Inc | DLB | Media - Diversified | 64.08 | 6.11B | 1.78% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 79 | 4.18B | 0.24% | 23.44 | 27.88% |
| Cinemark Holdings Inc | CNK | Media - Diversified | 28.48 | 3.49B | -0.42% | 27.93 | 934.91% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 27.25 | 3.39B | 0.96% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 60.04 | 3.35B | 1.06% | 14.48 | 170.51% |
| LCI Industries | LCII | Recreational Vehicles | 120.01 | 3.06B | -0.45% | 25.82 | 77.66% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 24.38 | 12.67 | Expensive |
| Ent. to Revenue | 1.87 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 2.29 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 35.59 | 59.59 | Lower Risk |
| Debt to Equity | 0.70 | -14.36 | Expensive |
| Debt to Assets | 0.28 | 0.34 | Par |
| Market Cap | 25.60B | 13.71B | Market Leader |